Diabetes, Cardiovascular Risks, and Lipoproteins

112 ta ish

1. Influence of abnormal lipid components in statin-naive young adults: Is there any gap?

   Jamol Uzokov

   BoshqaLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology201910 iqtibos

   ABIABI:AkademIndex/2019.other.000001

2. GW28-e0699 Cardiovascular risk stratification and gender differences in hypertensive patients with metabolic syndrome

   Alyavi Anis Lutfullayevich, Alyavi Baxrom Anisxonovich, Uzokov Jamol Kamilovich +2

   MaqolaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsJournal of the American College of Cardiology20177 iqtibos

   ABIABI:AkademIndex/2017.article.000213

3. Thrombolysis use in STEMI patients in Central Asia: lessons from the Bukhara region of Uzbekistan

   Dildora Aslonova, Rakhmon Amanov, Vokhid Zokirov +5

   MaqolaOAOchiq kirishAcute Myocardial Infarction ResearchFrontiers in Health Services20264 iqtibos

   ABIABI:AkademIndex/2026.article.000440

4. Influence of diet with low glycemic index on triglycerides, glycated hemoglobin and LDL-C/HDL-C ratio in patients with coronary artery disease

   Jamol Uzokov, Bakhromkhon Alyavi, Djamshid Payziev

   MaqolaLiver Disease Diagnosis and TreatmentAtherosclerosis20203 iqtibos

   ABIABI:AkademIndex/2020.article.000731

5. Assessing the Effectiveness of Type 2 Diabetes Screening in the Republic of Uzbekistan

   Anna Alieva, Anvar Alimov, Feruza Khaidarova +5

   MaqolaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsInternational Journal of Endocrinology and Metabolism20223 iqtibos

   ABIABI:AkademIndex/2022.article.000789

6. Triglyceride–glucose index: a potent predictor of metabolic risk factors and eating behavior patterns among obese individuals

   Amr Ali Mohamed Abdelgawwad El‐Sehrawy, Lusine Khachatryan, Aziz Kubaev +7

   MaqolaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsBMC Endocrine Disorders20253 iqtibos

   ABIABI:AkademIndex/2025.article.000201

7. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

   Antonio J. Vallejo‐Vaz, Martina De Marco, Christophe Stevens +82

   MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthAtherosclerosis20182 iqtibos

   ABIABI:AkademIndex/2018.article.000004

8. Prognostic value of metabolic syndrome for the development of type 2 diabetes mellitus and cardiovascular disease

   A. L. Alyavi, Bakhromkhon Alyavi, Jamol Uzokov

   MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsAtherosclerosis20202 iqtibos

   ABIABI:AkademIndex/2020.article.001193

9. Global burden of metabolic diseases, 1990–2021

   Huai Zhang, Xiaodong Zhou, Michael D. Shapiro +53

   MaqolaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsMetabolism20242 iqtibos

   ABIABI:AkademIndex/2024.article.000002

10. Patterns of adult tobacco use in Uzbekistan

    Gulnoza Usmanova, Yehuda Neumark, Mario Baras +1

    MaqolaOAOchiq kirishSmoking Behavior and CessationEuropean Journal of Public Health20111 iqtibos

    ABIABI:AkademIndex/2011.article.000153

11. Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle

    Aleksandr B. Shek, Rano Alieva, R. D. Kurbanov +4

    MaqolaLipoproteins and Cardiovascular HealthAtherosclerosis20181 iqtibos

    ABIABI:AkademIndex/2018.article.000323

12. INFLUENCE OF METABOLIC SYNDROME ON RENAL FUNCTION IN PATIENTS WITH HYPERTENSION

    Jamol Uzokov, Bakhromkhon Alyavi, Shukhratjon Azizov +1

    MaqolaBlood Pressure and Hypertension StudiesJournal of Hypertension20181 iqtibos

    ABIABI:AkademIndex/2018.article.000513

13. Burden of Ischemic Heart Disease in Central Asian Countries, 1990–2017

    Michelle Lui, Saeid Safiri, Alibek Mereke +10

    MaqolaOAOchiq kirishAcute Myocardial Infarction ResearchIJC Heart & Vasculature20211 iqtibos

    ABIABI:AkademIndex/2021.article.000229

14. Statins and dementia: effect of statins beyond the treatment of dyslipidaemia

    Jamol Uzokov

    BoshqaOAOchiq kirishLipoproteins and Cardiovascular HealthEuropean Journal of Preventive Cardiology20211 iqtibos

    ABIABI:AkademIndex/2021.other.000002

15. Features of the Trajectories of Glycated Hemoglobin in Patients with CHD and DM 2

    Раиса Тригулова, Sh.Sh. Mukhtarova, Dilnoza Alimova +2

    MaqolaNeurological Disorders and TreatmentsAmerican Heart Journal20231 iqtibos

    ABIABI:AkademIndex/2023.article.003329

16. DIAGNOSTICS AND TREATMENT OF CHRONIC CEREBRAL CIRCULATORY DISORDERS AGAINST THE BACKGROUND OF DIABETES MELLITUS

    Dzhurabekova Aziza Takhirovna, Shaymatov Rakhmonberdi Uktamovich

    MaqolaOAOchiq kirishDiabetes Management and ResearchThe American Journal of Medical Sciences and Pharmaceutical Research20231 iqtibos

    ABIABI:AkademIndex/2023.article.003785

17. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021

    Xiaodong Zhou, Qin‐Fen Chen, Wah Yang +48

    MaqolaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsEClinicalMedicine20241 iqtibos

    ABIABI:AkademIndex/2024.article.000004

18. Prediction of glycosylated hemoglobin level in patients with cardiovascular diseases and type 2 diabetes mellitus with respect to anti-diabetic medication

    Alisher Ikramov, Shakhnoza Mukhtarova, Раиса Тригулова +2

    MaqolaOAOchiq kirishDiabetes Treatment and ManagementFrontiers in Endocrinology20241 iqtibos

    ABIABI:AkademIndex/2024.article.001247

19. Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

    Amany Elshorbagy, Antonio J. Vallejo‐Vaz, Fotios Barkas +80

    MaqolaOAOchiq kirishLipoproteins and Cardiovascular HealthEuropean Heart Journal20251 iqtibos

    ABIABI:AkademIndex/2025.article.000498

20. Central obesity and glycaemic control in newly diagnosed type 2 diabetes mellitus patients: evidence from Uzbekistan

    Shukhrat Ziyadullaev, Shokhista Eshmuradova, Jonibek Kadirov +3

    MaqolaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsBMC Endocrine Disorders20261 iqtibos

    ABIABI:AkademIndex/2026.article.003225

21. Analysis of adult non-communicable disease (NCD) screening data in Uzbekistan using the UZ-SPEED NCD tool

    Khasanjon Odilov, Odgerel Chimed‐Ochir, Yui Yumiya +7

    MaqolaOAOchiq kirishHealth Promotion and Cardiovascular PreventionPublic Health20261 iqtibos

    ABIABI:AkademIndex/2026.article.005765

22. Influence of variability in risk factors on cardiovascular disease outcomes in type 2 diabetes mellitus

    Jamol Uzokov

    BoshqaOAOchiq kirishDiabetes, Cardiovascular Risks, and LipoproteinsEuropean Journal of Preventive Cardiology20231 iqtibos

    ABIABI:AkademIndex/2026.other.586760

23. QANDLI DIABET KASALLIGI FONIDA YURAK QON TOMIR TIZIMI KASALLIKLARINING KLINIK KECHUV XUSUSIYATLARI

    Исламова Камола Акрамовна, Карабаева Гульчехра Худойбердиевна

    MaqolaDiabetes, Cardiovascular Risks, and Lipoproteins20201 iqtibos

    ABIABI:AkademIndex/2026.other.721580

24. Comparison of simvastatin and guar gum in the treatment hyperlipidemic patients with diabetes mellitus II type

    K.M. Yafasov, G. Shamukhitdinova

    MaqolaDiabetes, Cardiovascular Risks, and LipoproteinsAtherosclerosis20000 iqtibos

    ABIABI:AkademIndex/2000.article.000271

25. Prooxidative Role of Hyperinsulinemia in Metabolic Sydrome Formation

    Nelli Uzbekova, Dilorom Abdullaevna Musakhodjaeva

    MaqolaOAOchiq kirishAdipose Tissue and MetabolismInternational Journal of Public Health Science (IJPHS)20140 iqtibos

    ABIABI:AkademIndex/2014.article.000443